Wittington Investments Acquires The Boots Group For $8.9 Billion

Advisers

The sellers and the target company engaged multiple financial institutions to manage the sale process and secure the final agreement. UBS Investment Bank and Rothschild & Co acted as the lead financial advisers to The Boots Group, according to a Wittington Investments, Limited press release distributed by Canada Newswire on October 7, 2026. The Boots Group also retained Citi, Deutsche Bank Securities Inc., Goldman Sachs, and J.P. Morgan as additional financial advisers.

For legal counsel, The Boots Group employed Davis Polk & Wardwell LLP, as stated in the same Canada Newswire release. Wittington Investments, Limited and Fairfax Financial Holdings did not disclose their legal or financial advisers in the official transaction announcements.

How the deal came about

The path to the transaction began when Sycamore Partners acquired Walgreens Boots Alliance for $23.7 billion in August 2025. The Financial Times reported on October 7, 2026, that Sycamore Partners immediately began evaluating exit options for The Boots Group. The private equity firm carved out the British retail pharmacy business and initiated a formal auction process in early 2026.

Several trade buyers and financial sponsors assessed the asset. In mid-2026, Australian pharmacy distributor Sigma Healthcare entered preliminary talks to acquire The Boots Group for approximately £7.5 billion. City AM reported on June 15, 2026, and Personal Care Insights noted on June 11, 2026, that Sigma Healthcare abandoned the auction process in June. The withdrawal of the Australian distributor removed the primary corporate competitor from the bidding process.

Following Sigma Healthcare’s exit, Wittington Investments, Limited adjusted its bidding strategy. Retail Gazette and The Telegraph reported on August 3, 2026, that the Weston family lowered its offer. This reduction caused a temporary stalemate in negotiations with Sycamore Partners. During this period, Sycamore Partners evaluated fallback plans, including a potential London Stock Exchange listing in late 2026 or 2027, as noted by The Guardian on October 7, 2026. The parties eventually resumed bilateral negotiations, culminating in the October 7 definitive agreement.

The Boots Group had previously attracted interest before Sycamore Partners owned the asset. Apollo Global Management, Reliance Industries, and TDR Capital submitted bids in 2022 when the target company carried an estimated valuation of up to £10 billion, according to The Guardian on October 7, 2026. Those historical bids did not result in a transaction.

Valuation and comparables

The $8.9 billion purchase price reflects the financial output of The Boots Group during its most recent fiscal year. Retail Gazette reported on August 3, 2026, that the company generated revenue of £7.5 billion and pre-tax profits of £337 million in the fiscal year ended August 31, 2025.

Wittington Investments, Limited, Fairfax Financial Holdings, and Sycamore Partners did not disclose specific enterprise value multiples, such as EV/EBITDA or EV/Sales, in the October 7, 2026, transaction filings. The parties based the negotiation on the cash generation of the United Kingdom and Ireland retail operations, the No7 Beauty Company, and Boots Opticians. The transaction perimeter excludes the Farmacias Benavides operations in Mexico and the Alliance Healthcare Deutschland business in Germany, which Sycamore Partners and Stefano Pessina will retain.

The valuation represents a decrease from the £10 billion estimates circulated during the 2022 auction process. The Guardian noted on October 7, 2026, that the earlier processes failed to close at those higher valuation targets. The current pricing structure aligns with the £7.5 billion valuation discussed during the aborted Sigma Healthcare talks in June 2026.

Financing and structure

The acquisition relies on a combination of committed equity capital and assumed debt. Fairfax Financial Holdings executed an equity commitment letter to provide funding for the transaction. A TSX regulatory release published via GlobeNewswire on October 7, 2026, confirmed that Fairfax Financial Holdings will supply up to approximately US$2.3 billion in equity funding. This contribution secures an indirect 50% equity stake for Fairfax Financial Holdings alongside Wittington Investments, Limited.

The $8.9 billion headline purchase price includes assumed debt from the target company’s balance sheet. The transaction announcements did not disclose the exact quantum of the debt Wittington Investments, Limited will assume. The official filings also omitted details regarding third-party underwriting facilities or specific leverage parameters applied to the operating company.

Wittington Investments, Limited will retain day-to-day operational control of The Boots Group despite the 50% equity stake held by Fairfax Financial Holdings. Galen Weston will join as Chairman, while Alex Baldock remains Chief Executive Officer of the retail chain.

Risks, conditions and key dates

The completion of the acquisition requires the parties to satisfy regulatory requirements across multiple jurisdictions.

• October 7, 2026: Wittington Investments, Limited and Sycamore Partners announce the definitive agreement. Fairfax Financial Holdings files the equity commitment notice on the TSX.
• Fourth quarter 2026: The transaction undergoes standard regulatory reviews, including mandatory competition clearance in the United Kingdom and other operating markets, as outlined in the October 7 GlobeNewswire release.
• First quarter 2027: The parties schedule the transaction to close, subject to the satisfaction of customary closing conditions. Canada Newswire and GlobeNewswire both reported this expected timeline on October 7, 2026.

Where reports disagree

Financial news organizations published differing figures regarding the exact consideration, primarily due to currency conversion timing and early leak reporting.

The official purchase price is US$8.9 billion. The Independent reported on October 7, 2026, that the purchase price translates to £6.7 billion. The Guardian, reporting on the same day, pegged the sterling consideration at £6.74 billion. The Canadian Press calculated the consideration at approximately C$12.7 billion on October 7, 2026.

Before the companies published the definitive agreement, media outlets circulated higher estimates based on negotiation leaks. The Wall Street Journal on September 30, 2026, and The Guardian on October 1, 2026, cited estimates of approximately $9 billion, or £7 billion. The final US$8.9 billion figure agreed upon by Wittington Investments, Limited and Sycamore Partners fell slightly below these late-September projections.